ST. PAUL, Minn.--(BUSINESS WIRE)--April 17, 2006--St. Jude Medical, Inc. (NYSE:STJ - News) today announced U.S. Food and Drug Administration (FDA) approval and market launch of its Merlin(TM) Patient Care System, a universal programmer for implantable cardioverter defibrillators (ICDs) and pacemakers. The system is designed to help physicians more efficiently conduct tests, analyze therapeutic and diagnostic data, and program implanted devices for optimal patient care.
